[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100522192":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":32,"responsibleParty":54,"collaborators":10,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":62,"eligibilityCriteria":63,"healthyVolunteers":64,"sex":65,"minAge":66,"maxAge":67,"enrollmentInfo":68,"targetDuration":10,"studyType":71,"phases":10,"briefSummary":72,"conditions":73,"keywords":75,"overallStatus":35,"whyStopped":10,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"Institut National de la Santé Et de la Recherche Médicale, France","OTHER_GOV",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Level of vascular aging",null,"community-based prospective longitudinal cohort",[13],"Other: high-precision carotid echo-tracking",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"OTHER","high-precision carotid echo-tracking","evaluation of vascular aging parameters and baroreflex sensitivity",[9],[21],{"name":22,"affiliation":5,"role":23},"Jean-Philippe Empana, MD, PhD","PRINCIPAL_INVESTIGATOR",[25,29],{"name":22,"role":26,"phone":27,"phoneExt":10,"email":28},"CONTACT","33153988020","jean-philippe.empana@inserm.fr",{"name":30,"role":26,"phone":10,"phoneExt":10,"email":31},"Xavier Jouven, MD, PhD","xavier.jouven@inserm.fr",[33],{"facility":34,"status":35,"city":36,"state":10,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"Centre d'Investigation Précliniques","RECRUITING","Paris","75016","France","FR",{"type":41,"coordinates":42},"Point",[43,44],2.3488,48.85341,{"lat":44,"lon":43},[47,51,53],{"name":48,"role":26,"phone":49,"phoneExt":10,"email":50},"Nicolas Danchin","0153673535","nicolas.danchin@egp.aphp.fr",{"name":52,"role":26,"phone":10,"phoneExt":10,"email":28},"Jean-Philippe Empana",{"name":52,"role":23,"phone":10,"phoneExt":10,"email":10},{"type":55,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100522192","risk-markers-of-arterial-aging-the-paris-prospective-study-iii-2-100522192",false,"NCT06079424","Risk Markers of Arterial Aging. The Paris Prospective Study III-2","Risk Markers of Arterial Aging and Subsequent Risk of Cardiovascular Diseases and Beyond. The Paris Prospective Study III-2","PPS3-2","Inclusion Criteria:\n\n* Being enrolled in PPS3 and having signed an informed consent for PPS3-2\n\nExclusion Criteria:\n\n* Institutionalized participants\n* Participants under guardianship\n* Participants under judicial safeguard measure",true,"ALL","60 Years","95 Years",{"count":69,"type":70},7500,"ESTIMATED","OBSERVATIONAL","The main objectives of PPS3-2 are (i) to describe the dynamics of vascular aging and baroreflex sensitivity 12 to 16 years a part, (ii) to identify their determinants, and (iii) to quantify the subsequent risk of cardiovascular diseases.",[74],"Arterial Stiffness",[76,77,78],"risk factors","cohort","cardiovascular diseases","2025-09-04",{"date":81,"type":82},"2025-09-11","ACTUAL",{"date":84,"type":82},"2025-06-20",{"date":86,"type":70},"2033-12",{"name":5,"class":6},1]